BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16704696)

  • 41. The Groningen Longitudinal Glaucoma Study. I. Baseline sensitivity and specificity of the frequency doubling perimeter and the GDx nerve fibre analyser.
    Heeg GP; Blanksma LJ; Hardus PL; Jansonius NM
    Acta Ophthalmol Scand; 2005 Feb; 83(1):46-52. PubMed ID: 15715556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes.
    Turpin A; McKendrick AM; Johnson CA; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):709-15. PubMed ID: 11867588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency doubling perimetry and the detection of eye disease in the community.
    Cioffi GA; Mansberger S; Spry P; Johnson C; Van Buskirk EM
    Trans Am Ophthalmol Soc; 2000; 98():195-9; discussion 199-202. PubMed ID: 11190023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detectability of glaucomatous changes using SAP, FDT, flicker perimetry, and OCT.
    Nomoto H; Matsumoto C; Takada S; Hashimoto S; Arimura E; Okuyama S; Shimomura Y
    J Glaucoma; 2009 Feb; 18(2):165-71. PubMed ID: 19225357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Humphrey visual field and frequency doubling perimetry in the diagnosis of early glaucoma.
    Chandrasekhar G; Kunjam V; Rao VS; Nutheti R
    Indian J Ophthalmol; 2003 Mar; 51(1):35-8. PubMed ID: 12701860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cataract extraction on frequency doubling technology perimetry.
    Kook MS; Yang SJ; Kim S; Chung J; Kim ST; Tchah H
    Am J Ophthalmol; 2004 Jul; 138(1):85-90. PubMed ID: 15234286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects.
    Chauhan BC; Johnson CA
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):648-56. PubMed ID: 10067968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of false positives with the Humphrey Field Analyzer II perimeter with the SITA Algorithm.
    Newkirk MR; Gardiner SK; Demirel S; Johnson CA
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4632-7. PubMed ID: 17003461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of cataract on the results of frequency-doubling technology perimetry.
    Tanna AP; Abraham C; Lai J; Shen J
    Ophthalmology; 2004 Aug; 111(8):1504-7. PubMed ID: 15288979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The SITA perimetric threshold algorithms in glaucoma.
    Wild JM; Pacey IE; O'Neill EC; Cunliffe IA
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1998-2009. PubMed ID: 10440254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of test duration as a screening criterion for frequency doubling perimetry.
    Thomas R; Parikh R; Muliyil J; Bhat S; George R
    Am J Ophthalmol; 2004 Mar; 137(3):562-3. PubMed ID: 15013885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic capability of optical coherence tomography (Stratus OCT 3) in early glaucoma.
    Parikh RS; Parikh S; Sekhar GC; Kumar RS; Prabakaran S; Babu JG; Thomas R
    Ophthalmology; 2007 Dec; 114(12):2238-43. PubMed ID: 17561260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the high specificity Screening Program (C-20-1) of the Frequency Doubling Technology (FDT) perimeter in clinical practice.
    North RV; Jones AL; Hunter E; Morgan JE; Wild JM
    Eye (Lond); 2006 Jun; 20(6):681-7. PubMed ID: 15999135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of catch trial methods used in standard automated perimetry in glaucoma patients.
    Wall M; Doyle CK; Brito CF; Woodward KR; Johnson CA
    J Glaucoma; 2008 Dec; 17(8):626-30. PubMed ID: 19092457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discrimination of glaucomatous optic neuropathy by digital stereoscopic analysis.
    Morgan JE; Sheen NJ; North RV; Goyal R; Morgan S; Ansari E; Wild JM
    Ophthalmology; 2005 May; 112(5):855-62. PubMed ID: 15878066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of age, sex, race, refractive error and optic disc parameters on the sensitivity and specificity of scanning laser polarimetry.
    Costa VP; Lauande-Pimentel R; Fonseca RA; Magacho L
    Acta Ophthalmol Scand; 2004 Aug; 82(4):419-25. PubMed ID: 15291935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma.
    Clement CI; Goldberg I; Healey PR; Graham S
    Br J Ophthalmol; 2009 May; 93(5):582-8. PubMed ID: 18669543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The results of screening frequency doubling technology perimetry in different locations of the community.
    Mansberger SL; Johnson CA; Cioffi GA
    J Glaucoma; 2007 Jan; 16(1):73-80. PubMed ID: 17224754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Correlation between confocal tomography of the optic nerve (HRT) and the perimetric frequency doubling technology].
    Sampaolesi R; Brusini P; Sampaolesi JR
    Klin Monbl Augenheilkd; 2003 Nov; 220(11):754-66. PubMed ID: 14634902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.